A New Integrated Clinical-Biohumoral Model to Predict Functionally Significant Coronary Artery Disease in Patients With Chronic Chest Pain.
暂无分享,去创建一个
Gianmario Sambuceti | Massimo Lombardi | Juhani Knuuti | Martina Marinelli | Danilo Neglia | Giancarlo Casolo | Stephen Schroeder | Clara Carpeggiani | Alessia Gimelli | Santiago Aguade | Rosa Sicari | Francesca Pugliese | Giancarlo Todiere | Daniele Rovai | Valentina Lorenzoni | Chiara Caselli | V. Lorenzoni | S. Schroeder | S. Nekolla | J. Zamorano | J. Knuuti | D. Neglia | M. Lombardi | P. Kaufmann | D. Le Guludec | F. Pugliese | G. Casolo | D. Rovai | G. Sambuceti | C. Caselli | M. Marinelli | A. Gimelli | R. Sicari | C. Carpeggiani | A. Scholte | S. Valente | D. Giannessi | S. R. Underwood | S Richard Underwood | S. Aguade | Philipp A Kaufmann | M. Pietila | A. Teresińska | G. Todiere | R. Poddighe | S. Del Ry | Mikko Pietila | Anna Teresinska | Rosa Poddighe | Dominique Le Guludec | Serafina Valente | Daniela Giannessi | Stephan Nekolla | José Zamorano | P. Perrone-filardi | Pasquale Perrone-Filardi | Arthur Scholte | Silvia Del Ry | Mikko Pietila | P. Kaufmann
[1] J. Kastelein,et al. Lipid parameters for measuring risk of cardiovascular disease , 2011, Nature Reviews Cardiology.
[2] Filippo Cademartiri,et al. Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts , 2012, BMJ : British Medical Journal.
[3] I. Shapira,et al. The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome , 2010 .
[4] J. Knuuti,et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[5] M. Riwanto,et al. High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease1 , 2013, Journal of Lipid Research.
[6] Sandeep S. Mangalmurti,et al. The Incremental Value of Lipids and Inflammatory Biomarkers in Determining Residual Cardiovascular Risk , 2011, Current atherosclerosis reports.
[7] D. Giannessi. Multimarker approach for heart failure management: perspectives and limitations. , 2011, Pharmacological research.
[8] P. Barter,et al. Antiinflammatory Properties of HDL , 2004 .
[9] Pamela S Douglas,et al. Low diagnostic yield of elective coronary angiography. , 2010, The New England journal of medicine.
[10] J. Lott,et al. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. , 1980, Clinical chemistry.
[11] P. Iozzo,et al. Interpretation of the "obesity paradox": a 30-year study in patients with cardiovascular disease. , 2013, International journal of cardiology.
[12] B. Zinman,et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. , 2004, Diabetes.
[13] C. Stefanadis,et al. Assessment of acute coronary syndromes: focus on novel biomarkers. , 2012, Current medicinal chemistry.
[14] Hatem Alkadhi,et al. A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. , 2011, European heart journal.
[15] Jose Luis Zamorano,et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[16] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[17] P. Libby,et al. Controversies in cardiovascular medicine Clinical implications of inflammation for cardiovascular primary prevention , 2010 .
[18] G. Diamond,et al. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. , 1979, The New England journal of medicine.
[19] Eckart Fleck,et al. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. , 2003, European heart journal.
[20] S. Saadat,et al. The Association of Liver Transaminase Activity With Presence and Severity of Premature Coronary Artery Disease , 2011, Angiology.
[21] J. Gallacher,et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. , 2012, The New England journal of medicine.
[22] R. Vasan,et al. Aminotransferase Levels Are Associated With Cardiometabolic Risk Above and Beyond Visceral Fat and Insulin Resistance: The Framingham Heart Study , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[23] A. Papavassiliou,et al. Novel risk factors related to stable angina. , 2013, Current pharmaceutical design.
[24] Jeroen J. Bax,et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.
[25] Gian Franco Gensini,et al. Detection of Significant Coronary Artery Disease by Noninvasive Anatomical and Functional Imaging , 2015, Circulation. Cardiovascular imaging.
[26] R. Dhir,et al. Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography , 2012, BMC Medicine.